Global and United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Report & Forecast 2022-2028

Publisher Name :
Date: 17-May-2022
No. of pages: 94
Inquire Before Buying

Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

- Pediatric Hepatitis B (CHO) Vaccine

- Adult Hepatitis B (CHO) Vaccine

Segment by Application

- Hospitals

- Clinics

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Merck & Co., Inc.

- GlaxoSmithKline Plc

- Pfizer Inc.

- Sanofi Pasteur

- CSL Limited

- Emergent Biosolutions

- Serum Institute of India

- Johnson & Johnson

Global and United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction
1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Outlook 2017 VS 2022 VS 2028
1.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in US$ Million for the Year 2017-2028
1.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume for the Year 2017-2028
1.3 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Outlook 2017 VS 2022 VS 2028
1.3.1 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in US$ Million for the Year 2017-2028
1.3.2 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume for the Year 2017-2028
1.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Dynamics
1.5.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Trends
1.5.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Drivers
1.5.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Challenges
1.5.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Segment by Type
2.1.1 Pediatric Hepatitis B (CHO) Vaccine
2.1.2 Adult Hepatitis B (CHO) Vaccine
2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Type
2.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Type
2.3.1 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Application
3.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Application
3.3.1 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Competitor Landscape by Company
4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Company
4.1.1 Top Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturers Ranked by Revenue (2021)
4.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Manufacturer (2017-2022)
4.1.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Manufacturer (2017-2022)
4.1.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Manufacturer (2017-2022)
4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Concentration Ratio (CR)
4.2.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in 2021
4.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturing Base Distribution, Product Type
4.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Type
4.3.3 Date of International Manufacturers Enter into Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Company
4.5.1 Top Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Players in United States, Ranked by Revenue (2021)
4.5.2 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Players (2020, 2021 & 2022)
5 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Region
5.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size in Volume by Region (2017-2028)
5.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Region: 2017-2022
5.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume Forecast by Region (2023-2028)
5.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size in Value by Region (2017-2028)
5.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Region: 2017-2022
5.3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size YoY Growth 2017-2028
6.1.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size YoY Growth 2017-2028
6.3.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size YoY Growth 2017-2028
6.4.2 Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Corporation Information
7.1.2 Merck & Co., Inc. Description and Business Overview
7.1.3 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
7.1.5 Merck & Co., Inc. Recent Development
7.2 GlaxoSmithKline Plc
7.2.1 GlaxoSmithKline Plc Corporation Information
7.2.2 GlaxoSmithKline Plc Description and Business Overview
7.2.3 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.2.4 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
7.2.5 GlaxoSmithKline Plc Recent Development
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Corporation Information
7.3.2 Pfizer Inc. Description and Business Overview
7.3.3 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
7.3.5 Pfizer Inc. Recent Development
7.4 Sanofi Pasteur
7.4.1 Sanofi Pasteur Corporation Information
7.4.2 Sanofi Pasteur Description and Business Overview
7.4.3 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
7.4.5 Sanofi Pasteur Recent Development
7.5 CSL Limited
7.5.1 CSL Limited Corporation Information
7.5.2 CSL Limited Description and Business Overview
7.5.3 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.5.4 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
7.5.5 CSL Limited Recent Development
7.6 Emergent Biosolutions
7.6.1 Emergent Biosolutions Corporation Information
7.6.2 Emergent Biosolutions Description and Business Overview
7.6.3 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
7.6.5 Emergent Biosolutions Recent Development
7.7 Serum Institute of India
7.7.1 Serum Institute of India Corporation Information
7.7.2 Serum Institute of India Description and Business Overview
7.7.3 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
7.7.5 Serum Institute of India Recent Development
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Corporation Information
7.8.2 Johnson & Johnson Description and Business Overview
7.8.3 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Products Offered
7.8.5 Johnson & Johnson Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Chain Analysis
8.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors
8.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Mode & Process
8.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and Marketing
8.4.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Channels
8.4.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors
8.5 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Trends
Table 3. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Drivers
Table 4. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Challenges
Table 5. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Restraints
Table 6. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Manufacturer, 2017-2022
Table 13. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Manufacturer, (K Doses), 2017-2022
Table 14. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Manufacturer, 2017-2022
Table 15. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Manufacturer (2017-2022) & (USD/Dose)
Table 16. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine as of 2021)
Table 18. Top Players of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Type
Table 20. Date of International Manufacturers Enter into Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Players, (K Doses), 2020, 2021 & 2022
Table 26. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Region (2017-2022) & (K Doses)
Table 29. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume Forecast by Region (2023-2028) & (K Doses)
Table 30. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 33. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Region (2017-2028) & (K Doses)
Table 35. Asia Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 37. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 39. Latin Americaa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 41. Middle East and Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Merck & Co., Inc. Corporation Information
Table 43. Merck & Co., Inc. Description and Business Overview
Table 44. Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 45. Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product
Table 46. Merck & Co., Inc. Recent Development
Table 47. GlaxoSmithKline Plc Corporation Information
Table 48. GlaxoSmithKline Plc Description and Business Overview
Table 49. GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 50. GlaxoSmithKline Plc Product
Table 51. GlaxoSmithKline Plc Recent Development
Table 52. Pfizer Inc. Corporation Information
Table 53. Pfizer Inc. Description and Business Overview
Table 54. Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 55. Pfizer Inc. Product
Table 56. Pfizer Inc. Recent Development
Table 57. Sanofi Pasteur Corporation Information
Table 58. Sanofi Pasteur Description and Business Overview
Table 59. Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 60. Sanofi Pasteur Product
Table 61. Sanofi Pasteur Recent Development
Table 62. CSL Limited Corporation Information
Table 63. CSL Limited Description and Business Overview
Table 64. CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 65. CSL Limited Product
Table 66. CSL Limited Recent Development
Table 67. Emergent Biosolutions Corporation Information
Table 68. Emergent Biosolutions Description and Business Overview
Table 69. Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 70. Emergent Biosolutions Product
Table 71. Emergent Biosolutions Recent Development
Table 72. Serum Institute of India Corporation Information
Table 73. Serum Institute of India Description and Business Overview
Table 74. Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 75. Serum Institute of India Product
Table 76. Serum Institute of India Recent Development
Table 77. Johnson & Johnson Corporation Information
Table 78. Johnson & Johnson Description and Business Overview
Table 79. Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 80. Johnson & Johnson Product
Table 81. Johnson & Johnson Recent Development
Table 82. Key Raw Materials Lists
Table 83. Raw Materials Key Suppliers Lists
Table 84. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers List
Table 85. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors List
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Picture
Figure 2. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size 2017-2028 (US$ Million)
Figure 4. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales 2017-2028 (K Doses)
Figure 5. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size 2017-2028 (US$ Million)
Figure 7. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales 2017-2028 (K Doses)
Figure 8. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share in Global, in Volume (K Doses) 2017-2028
Figure 10. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Report Years Considered
Figure 11. Product Picture of Pediatric Hepatitis B (CHO) Vaccine
Figure 12. Product Picture of Adult Hepatitis B (CHO) Vaccine
Figure 13. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Type in 2022 & 2028
Figure 14. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2017-2028) & (K Doses)
Figure 17. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2017-2028) & (USD/Dose)
Figure 19. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Type in 2022 & 2028
Figure 20. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2017-2028) & (K Doses)
Figure 23. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2017-2028) & (USD/Dose)
Figure 25. Product Picture of Hospitals
Figure 26. Product Picture of Clinics
Figure 27. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Application in 2022 & 2028
Figure 28. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
Figure 29. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Application (2017-2028)
Figure 30. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2017-2028) & (K Doses)
Figure 31. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Application (2017-2028)
Figure 32. Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application (2017-2028) & (USD/Dose)
Figure 33. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share by Application in 2022 & 2028
Figure 34. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Value by Application (2017-2028)
Figure 36. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2017-2028) & (K Doses)
Figure 37. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Market Share in Volume by Application (2017-2028)
Figure 38. United States Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application (2017-2028) & (USD/Dose)
Figure 39. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 40. North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 41. U.S. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 42. Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 44. Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. Germany Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. France Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. U.K. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Italy Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Russia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 51. Asia-Pacific Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 52. China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. South Korea Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Australia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Taiwan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Indonesia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Thailand Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Malaysia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Philippines Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 63. Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 64. Mexico Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Brazil Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Argentina Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 68. Middle East & Africa Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Turkey Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Saudi Arabia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. U.A.E Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Value Chain
Figure 73. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Process
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
  • Global Megestrol Acetate (Megace) Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 96
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Suspension - Tablets Segment by Application - Hospital - Clinic - Other ......
  • Global Oxcarbazepine Tablets Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 116
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Tablets (150mg) - Tablets (300mg) - Tablets (600mg) Segment by Application - Hospital......
  • Global Oxcarbazepine API Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 116
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Medical Grade - Other Segment by Application - Tablets - Oral Suspension - Oth......
  • Global Therapeutic Dog Food Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 100
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Dry Food - Wet/Canned Food - Fresh Food - Snacks/treats - Others Segment by Ap......
  • Global Transtympanic Injectable Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 90
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Corticosteroid - Aminoglycosides Segment by Application - Hospitals - ENT Clinics......
  • Global Enzyme Indicators Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 119
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Bio-decontamination - Drug Development - Pesticide Synthesis Segment by Application -......
  • Global Stool Softeners Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 102
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Liquid - Softgel Capsule - Enema Segment by Application - Hospitals - Clinics......
  • Global Std Self Diagnostics Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 94
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Testing Kit - Testing Device - Testing Strip/chip Segment by Application - Hospitals......
  • Global Eye Drops for Contact Lens Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - = 10ml - > 10ml Segment by Application - Online Channel - Offline Channel ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs